Profund Advisors’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Profund Advisors's ANAB Position: Q2 2026 in Review
Profund Advisors reduced its AnaptysBio (ANAB) stake by 9.5% in Q2 2026, selling an estimated $70.2K and leaving 11,044 shares worth $745K. The position accounts for 0.02% of the portfolio, ranked #420.
Profund Advisors first reported a position in ANAB in Q1 2023 and has held it in 11 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Profund Advisors held 11,044 shares of AnaptysBio worth $745K as of Q2 2026.
- Profund Advisors sold 1,158 AnaptysBio shares in Q2 2026, an estimated $70.2K.
- AnaptysBio made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #420 holding.
- Profund Advisors first reported a position in AnaptysBio in Q1 2023 and has held it in 11 quarters since.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.